The Immunohaematology business is a stand-alone business unit operating under Seqirus, formerly bioCSL.
Our core skills include the manufacture of Reagent Red Blood Cells (RRBCs), monoclonal antibodies and the production of reagents and ancillary products for immunohaematology laboratories.
We supply vital RRBCs to Australian transfusion and pathology laboratories and work closely with:
- Australian Commonwealth Government Department of Health and Ageing
- National Blood Authority
- Australian Red Cross Blood Service